Literature DB >> 30794806

Intrinsic Bone Defects in Cystinotic Mice.

Giulia Battafarano1, Michela Rossi1, Laura R Rega2, Gianna Di Giovamberardino3, Anna Pastore4, Matteo D'Agostini5, Ottavia Porzio6, Nathalie Nevo7, Francesco Emma8, Anna Taranta9, Andrea Del Fattore1.   

Abstract

Cystinosis is a rare lysosomal storage disorder caused by loss-of-function mutations of the CTNS gene, encoding cystinosin, a symporter that mediates cystine efflux from lysosomes. Approximately 95% of patients with cystinosis display renal Fanconi syndrome, short stature, osteopenia, and rickets. In this study, we investigated whether the absence of cystinosin primarily affects bone remodeling activity, apart from the influences of the Fanconi syndrome on bone mineral metabolism. Using micro-computed tomography and histomorphometric and bone serum biomarker analysis, we evaluated the bone phenotype of 1-month-old Ctns-/- knockout (KO) male mice without tubulopathy. An in vitro study was performed to characterize the effects of cystinosin deficiency on osteoblasts and osteoclasts. Micro-computed tomography analysis showed a reduction of trabecular bone volume, bone mineral density, and number and thickness in KO mice compared with wild-type animals; histomorphometric analysis revealed a reduction of osteoblast and osteoclast parameters in tibiae of cystinotic mice. Decreased levels of serum procollagen type 1 amino-terminal propeptide and tartrate-resistant acid phosphatase in KO mice confirmed reduced bone remodeling activity. In vitro experiments showed an impairment of Ctns-/- osteoblasts and osteoclasts. In conclusion, cystinosin deficiency primarily affects bone cells, leading to a bone loss phenotype of KO mice, independent from renal failure.
Copyright © 2019 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30794806     DOI: 10.1016/j.ajpath.2019.01.015

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  6 in total

1.  Management of bone disease in cystinosis: Statement from an international conference.

Authors:  Katharina Hohenfellner; Frank Rauch; Gema Ariceta; Atif Awan; Justine Bacchetta; Carsten Bergmann; Susanne Bechtold; Noelle Cassidy; Geroges Deschenes; Ewa Elenberg; William A Gahl; Oliver Greil; Erik Harms; Nadine Herzig; Bernd Hoppe; Christian Koeppl; Malcolm A Lewis; Elena Levtchenko; Galina Nesterova; Fernando Santos; Karl P Schlingmann; Aude Servais; Neveen A Soliman; Guenther Steidle; Clodagh Sweeney; Ulrike Treikauskas; Rezan Topaloglu; Alexey Tsygin; Koenraad Veys; Rodo V Vigier; Jozef Zustin; Dieter Haffner
Journal:  J Inherit Metab Dis       Date:  2019-08-05       Impact factor: 4.982

Review 2.  Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy.

Authors:  Irma Machuca-Gayet; Thomas Quinaux; Aurélia Bertholet-Thomas; Ségolène Gaillard; Débora Claramunt-Taberner; Cécile Acquaviva-Bourdain; Justine Bacchetta
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

Review 3.  In Vitro and In Vivo Models to Study Nephropathic Cystinosis.

Authors:  Pang Yuk Cheung; Patrick T Harrison; Alan J Davidson; Jennifer A Hollywood
Journal:  Cells       Date:  2021-12-21       Impact factor: 6.600

Review 4.  Muscle and Bone Impairment in Infantile Nephropathic Cystinosis: New Concepts.

Authors:  Dieter Haffner; Maren Leifheit-Nestler; Candide Alioli; Justine Bacchetta
Journal:  Cells       Date:  2022-01-05       Impact factor: 6.600

5.  Patients With Infantile Nephropathic Cystinosis in Germany and Austria: A Retrospective Cohort Study.

Authors:  Nina O'Connell; Jun Oh; Klaus Arbeiter; Anja Büscher; Dieter Haffner; Jessica Kaufeld; Christine Kurschat; Christoph Mache; Dominik Müller; Ludwig Patzer; Lutz T Weber; Burkhard Tönshoff; Marcus Weitz; Katharina Hohenfellner; Lars Pape
Journal:  Front Med (Lausanne)       Date:  2022-04-25

6.  Multisystem involvement, defective lysosomes and impaired autophagy in a novel rat model of nephropathic cystinosis.

Authors:  Patrick Krohn; Laura Rita Rega; Marianne Harvent; Beatrice Paola Festa; Anna Taranta; Alessandro Luciani; Joseph Dewulf; Alessio Cremonesi; Francesca Diomedi Camassei; James V M Hanson; Christina Gerth-Kahlert; Francesco Emma; Marine Berquez; Olivier Devuyst
Journal:  Hum Mol Genet       Date:  2022-07-07       Impact factor: 5.121

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.